Screening Infants and Children at Risk for Fractures Clinical Pathway — Inpatient
Screening Infants and Children at Risk for Fractures Clinical Pathway — Inpatient
Child Risk Factors for Metabolic Bone Disease, Osteopenia and Fractures
Child Condition/Treatment | Rationale |
---|---|
Non-ambulatory Status or Recent Significant Decrease in Ambulatory Status or Weightbearing Activity | Chronic muscle weakness and diminished weight bearing weaken bones because of impaired bone density and strength accrual. Acute loss of weight bearing leads to frank loss of bone mineral due to an imbalance of bone resorption and formation. |
Parenteral Nutrition (PN) > 4 wks | Difficult to provide adequate mineral intake from PN regimens to meet demands of growing skeleton. |
Systemic (IV/PO) Steroids > 14 days | Acute initiation of high dose steroids for >14 days weakens bones due to increased bone resorption. Vertebral fractures can occur as soon as 30 days following onset of treatment. Chronic steroid exposure weakens bone through suppressed bone formation leading to impaired accrual of bone density and strength. |
Severe Neuromuscular Disease |
|
Osteopenia, Demineralization, or “Gracile Bones” Reported on Radiograph |
These findings suggest impaired accrual of bone density and strength. |
Loop Diuretic Use > 14 Days | These medications lead to urinary wasting of calcium that can contribute to secondary hyperparathyroidism and/or impaired bone mineral accrual. |
Disorders Resulting in Malabsorption
|
|
Restrictive Diets | Restrictive diets due to multiple food allergies, autism or disordered eating can result in inadequate nutrient intake, contributing to metabolic bone disease. |
Primary Bone Disorders
- Osteogenesis imperfecta
- Genetic vitamin D disorders
- Hypophosphatasia
- Osteopetrosis